Camella-Pozuela et al. showed that plasma CT-1 levels are higher in patients with type 2 diabetes (T2DM) or impaired glucose tolerance compared to controls, with positive correlations with glycemia, blood pressure, and left ventricular hypertrophy, decreased ankle-brachial index, and microalbuminuria [62,102]. The gene discussed is CTF1; the disease is type 2 diabetes mellitus.